2018
DOI: 10.20944/preprints201804.0126.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

2017 FDA Peptide Harvest

Abstract: approved by the FDA, with a total of forty-six. In turn, one of the highlights was the number of 14 peptides (six) included in this list. Here, the six peptides are analysed in terms of chemical structure, 15synthetic strategy used for their production, source, biological target, and mode of action. 16

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
8
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 27 publications
(40 reference statements)
1
8
0
Order By: Relevance
“…Hence, the recent revival of peptide‐based drugs both in academia and in the pharmaceutical industry comes with no surprise, as peptide therapeutics can address many unmet medical needs, by complementing or even replacing small molecules or large protein‐based therapeutics currently in the clinics (Craik, Fairlie, Liros, & Price, ; Henninot, Collins, & Nuss, ; Otvos Jr. & Wade, ). Accordingly, peptide drug sales have been steadily increasing, at present having an expected volume of sales likely over US$ 70 billion in 2019 (insulins included) (Henninot et al, ), and US$ 47 billion (insulins excluded) by 2024 (Al Musaimi, Al Shaer, de la Torre, & Albericio, ).…”
Section: Peptides As Drugs: Challenges and Perspectivesmentioning
confidence: 99%
“…Hence, the recent revival of peptide‐based drugs both in academia and in the pharmaceutical industry comes with no surprise, as peptide therapeutics can address many unmet medical needs, by complementing or even replacing small molecules or large protein‐based therapeutics currently in the clinics (Craik, Fairlie, Liros, & Price, ; Henninot, Collins, & Nuss, ; Otvos Jr. & Wade, ). Accordingly, peptide drug sales have been steadily increasing, at present having an expected volume of sales likely over US$ 70 billion in 2019 (insulins included) (Henninot et al, ), and US$ 47 billion (insulins excluded) by 2024 (Al Musaimi, Al Shaer, de la Torre, & Albericio, ).…”
Section: Peptides As Drugs: Challenges and Perspectivesmentioning
confidence: 99%
“…Peptides play an important role in the fields of drug discovery and delivery [8][9][10], immunology [11], diagnostics [12], and biomaterials [13]. This relevance is attributed to their potential as drugs with high efficacy and minimal side effects.…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, hundreds of peptides are currently being tested in preclinical trials. In addition, about 150 peptides have yielded promising results in clinical phases, and approximately 70 others are already on the market [8,9,14,15].…”
Section: Introductionmentioning
confidence: 99%
“…They have also been shown to have several advantages, such as effectiveness at extremely low concentrations (due to their very high specificity) and their non-accumulation in the human body or the environment after being excreted. As a consequence of these advantages, the relevance of peptide pharmaceuticals (e.g., as antitumoral, anticoagulant, anti-hypertensive, antioxidant, antimicrobial drugs) began to increase [ 3 , 7 , 8 , 9 , 10 ].…”
Section: Introductionmentioning
confidence: 99%